TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2021

Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease.

Mark Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.